ELANElanco Animal Health Inc

Is Elanco Animal Health Incorporated (ELAN) Positioned for Long-Term Growth With Seven Potential Blockbuster Launches...

Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health PR Newswire INDIANAPOLIS, June 18, 2026 New corporate venture capital...

Elanco Announces USDA Approval of TruCan Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs Elanco Announces USDA Approval of TruCan Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs PR Newswire...

Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm PR Newswire INDIANAPOLIS, June 4, 2026 Company offers...

New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience New Research Reveals Pet Spending as a "Protected Budget Item" for Owners, Fueling Industry Resilience PR Newswire INDIANAPOLIS, June 3, 2026 INDIANAPOLIS, June 3, 2026 /PRNewswire/ -- Elanco...

Elanco Launches Befrena (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market Elanco Launches Befrena (tirnovetmab), New...

Elanco to Participate in Upcoming Investor Conferences Elanco to Participate in Upcoming Investor Conferences PR Newswire INDIANAPOLIS, May 14, 2026 INDIANAPOLIS, May 14, 2026 /PRNewswire/ -- Elanco...

On today's episode, Carol Massar and Tim Stenovec speaks Mike McKee, Bloomberg TV and Radio International Economics & Policy Correspondent on his interview with Mary Daly. They also spoke to Jeff...

Elanco Animal Health (NYSE:ELAN - Get Free Report) released its quarterly earnings results on Wednesday. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.34 by $0.06. Elanco Animal Health had a negative net margin of 4.92% and a...